U.S. Computer Aided Detection (CAD) Market, By Product Type (Software and Services), Imaging Modality (Breast Imaging, Lung Imaging, Oncology and Radiation, Abdominal and Pelvic Imaging, Dental Imaging, Cardiovascular Imaging, and Others), Application (Cancer, Neurological Disorders, Cardiovascular Diseases, Musculoskeletal Diseases, and Others), Mode of Purchase (Group Purchase Organization and Individual), End User (Hospitals, Diagnostic Centers, Research Centers and Academic Institutes, and Others) - Industry Trends and Forecast to 2031.
U.S. Computer Aided Detection (CAD) Market Analysis and Size
The key factor fueling the market expansion is the increasing technological advancements. The rising application of CAD systems in the medical field is driving the market growth. In addition, the government initiatives for CAD systems will open up more business potential for the market. However, the major restraint impacting the market is the lack of skillful medical professionals. On the other hand, the increasing awareness regarding accurate diagnosis is expected to create opportunities for market growth.
Data Bridge Market Research analyzes that the U.S. Computer Aided Detection (CAD) market is expected to reach USD 1,826.95 million by 2031 from USD 742.32 million in 2023, growing with a CAGR of 12.0% in the forecast period of 2024 to 2031.
Report Metric |
Details |
Forecast Period |
2024 to 2031 |
Base Year |
2023 |
Historic Years |
2022 (Customizable 2016-2021) |
Quantitative Units |
Revenue in USD Million |
Segments Covered |
Product Type (Software and Services), Imaging Modality (Breast Imaging, Lung Imaging, Oncology and Radiation, Abdominal and Pelvic Imaging, Dental Imaging, Cardiovascular Imaging, and Others), Application (Cancer, Neurological Disorders, Cardiovascular Diseases, Musculoskeletal Diseases, and Others), Mode of Purchase (Group Purchase Organization and Individual), End User (Hospitals, Diagnostic Centers, Research Centers and Academic Institutes, and Others) |
Country Covered |
U.S. |
Market Players Covered |
Koninklijke Philips N.V., FUJIFILM Holdings Corporation, CANON MEDICAL SYSTEMS CORPORATION, Siemens Healthcare GmbH, Median Technologies, General Electric Company, Hologic, Inc., iCAD, Inc., EDDA Technology, Inc., and Riverain Technologies among others |
Market Definition
The term "Computer-Aided Detection" (CAD) describes the process of interpreting medical imaging investigations, such as X-rays, CT scans, and MRIs, by using computer algorithms and software. Areas of interest or possible abnormalities in the images are highlighted and flagged by CAD systems so that a radiologist or other healthcare provider can investigate them further. These systems analyze patterns, shapes, and densities in the images to increase diagnosis efficiency and accuracy by highlighting areas needing more examination. CAD is a useful tool in the diagnosis process that helps medical professionals comprehend and make decisions, even if it cannot replace human skills.
U.S. Computer Aided Detection (CAD) Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Rising Application of Computer-Aided Detection (CAD) Systems in the Medical Field
The market for CAD systems is growing and evolving due to the growing implementation of these systems in various medical disciplines. CAD systems were widely used in radiology to identify complexities in images, such as mammograms, but they have quickly spread to many other medical specialties. The growing use of CAD systems in specialty areas other than radiology—pathology, cardiology, oncology, and neurology—indicates their adaptability and effectiveness in supporting medical personnel in a variety of disciplines. Healthcare procedures are being revolutionized by CAD's capacity to provide early identification, precise diagnosis, and treatment planning for a variety of illnesses.
The market potential of CAD applications is raised by their diversification, drawing in more healthcare professionals who are looking for diagnostic instruments that are more precise and efficient. The increasing adoption rates of CAD systems, which demonstrate their efficacy in several medical specialties, are driving technological improvements and market expansion.
The increasing adoption and use of CAD systems in a range of medical specialties highlights their revolutionary influence on the provision of healthcare. The use of these systems in a variety of specializations is growing as they show promise in facilitating earlier and more accurate diagnoses, improved treatment outcomes, and improved patient care. Thus, the rising application of CAD system in medical field is driving market growth.
- Increasing Technological Advancements Associated with CAD
The primary factor behind the growth and expansion of the CAD market in the healthcare sector is technological advancements. These developments keep CAD systems up to date and improve their adaptability, precision, and capacity for diagnosing a wide range of medical disorders. The development of deep learning algorithms, machine learning, and Artificial Intelligence (AI) has been essential to the advancement of CAD systems. These developments make it possible for CAD software to process enormous volumes of medical imaging data at previously unheard-of speeds and precision. This results in the more accurate and dependable identification of anomalies in MRIs, CT scans, X-rays, and other imaging modalities.
CAD systems will advance in detection, adaptability, and integration with healthcare ecosystems as technological advancements continue. The market is growing as a result of the CAD industry's unwavering application of technology improvements, which have the enormous potential to revolutionize patient care, improve diagnostic capabilities, and influence the direction of healthcare. Thus, the increasing technological advancements is driving market growth.
Opportunity
- Advanced Healthcare Infrastructure in the U.S.
The advanced healthcare infrastructure in the U.S. is a factor for creating significant opportunities in the market. In the U.S., the well-established network of hospitals and diagnostic centers, coupled with sophisticated medical facilities, provides a fertile ground for the seamless integration of CAD technologies. The robust infrastructure accelerates the adoption of CAD systems, enhancing the efficiency and accuracy of medical imaging and diagnostics.
In the U.S., the advanced healthcare infrastructure not only establishes a foundation for the implementation of CAD but also reflects a commitment to leveraging cutting-edge technologies to enhance patient care. This commitment, combined with the technological readiness of healthcare systems, creates an environment where CAD can thrive, offering advanced diagnostic capabilities that contribute to more accurate and timely medical interventions, which is expected to create opportunities for market growth.
Restraint/Challenge
- High Cost of Computer Aided Detection (CAD) Systems
Many healthcare facilities find it difficult to integrate CAD systems into their diagnostic workflows due to the initial investment necessary for CAD system acquisition and implementation. Medical imaging-specific hardware and software are frequently needed for CAD systems. These systems might have expensive upfront costs, particularly for smaller healthcare facilities or those with tighter budgets.
The total cost of ownership includes additional expenses for continuing maintenance, updates, and licensing after the initial expenditure. The cost is increased by having to make sure the system is current with new developments and complies with legal requirements. It takes more time and resources to train healthcare workers on how to utilize CAD systems efficiently and seamlessly integrate them into current operations. There are expenses associated with this training for both the initial deployment and ongoing instruction as new features or updates are released. For CAD systems to remain updated with changing medical practices, technology breakthroughs, and regulatory requirements, regular updates and upgrades are necessary. Updates to the hardware and software are extra costs associated with keeping the system updated. Medical staff must receive ongoing training to retain their competency with CAD technology. Continual training programs come with costs for employee education and skill improvement.
Healthcare providers, especially smaller practices or institutions with limited funds, have been reluctant to use CAD systems due to their high cost. Patients' access to the advantages of CAD systems' more precise and effective diagnoses is restricted by this adoption barrier. The financial resources of healthcare institutions, particularly smaller practices or those with low resources, are strained by the cumulative effect of maintenance expenditures. Thus, the high cost of CAD systems is restraining the market growth.
U.S. Computer Aided Detection (CAD) Market Scope
The U.S. Computer Aided Detection (CAD) market is segmented into five notable segments based on product type, imaging modality, application, mode of purchase, and end user. The growth amongst these segments will help you analyse major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Software
- services
On the basis of product type, the U.S. Computer Aided Detection (CAD) market is segmented software and services.
Imaging Modality
- Oncology and Radiation
- Breast Imaging
- Lung Imaging
- Cardiovascular Imaging
- Abdominal and Pelvic Imaging
- Dental Imaging
- Others
On the basis of imaging modality, the U.S. Computer Aided Detection (CAD) market is segmented into breast imaging, lung imaging, oncology and radiation, abdominal and pelvic imaging, dental imaging, cardiovascular imaging, and others.
Application
- Cancer
- Neurological Disorders
- Cardiovascular Diseases
- Musculoskeletal Diseases
- Others
On the basis of application, the market is segmented into cancer, neurological disorders, cardiovascular diseases, musculoskeletal diseases, and others.
Mode of Purchase
- Group Purchase Organization
- Individual
On the basis of mode of purchase, the U.S. Computer Aided Detection (CAD) market is segmented into group purchase organization and individual.
End User
- Hospitals
- Diagnostic Centers
- Research Institutes and Academic Centers
- Others
On the basis of end user, the U.S. Computer Aided Detection (CAD) market is segmented into hospitals, diagnostic centers, research centers and academic institutes, and others.
Competitive Landscape and U.S. Computer Aided Detection (CAD) Market Share Analysis
The U.S. Computer Aided Detection (CAD) market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, country presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus on the market.
Some of the major market players operating in the U.S. Computer Aided Detection (CAD) market are Koninklijke Philips N.V., FUJIFILM Holdings Corporation, CANON MEDICAL SYSTEMS CORPORATION, Siemens Healthcare GmbH, Median Technologies, General Electric Company, Hologic, Inc., iCAD, Inc., EDDA Technology, Inc., and Riverain Technologies, among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 MULTIVARIATE MODELLING
2.8 TYPE LIFELINE CURVE
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING APPLICATION OF COMPUTER-AIDED DETECTION (CAD) SYSTEMS IN THE MEDICAL FIELD
5.1.2 INCREASING TECHNOLOGICAL ADVANCEMENTS ASSOCIATED WITH CAD
5.1.3 GOVERNMENT INITIATIVES FOR COMPUTER AIDED DETECTION (CAD) SYSTEMS
5.2 RESTRAINTS
5.2.1 HIGH COST OF COMPUTER AIDED DETECTION (CAD) SYSTEMS
5.2.2 STRICT GUIDELINES FOR COMPUTER AIDED DETECTION (CAD)
5.3 OPPORTUNITIES
5.3.1 ADVANCED HEALTHCARE INFRASTRUCTURE OF THE COUNTRIES
5.3.2 INCREASING AWARENESS REGARDING ACCURATE DIAGNOSIS
5.4 CHALLENGE
5.4.1 DEPENDENCY ON SKILLED MEDICAL PROFESSIONALS
6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 SOFTWARE
6.2.1 INTEGRATED CAD
6.2.1.1 CLOUD-BASED
6.2.1.2 ON-PREMISES
6.2.2 STANDALONE CAD
6.2.2.1 CLOUD-BASED
6.2.2.2 ON-PREMISES
6.3 SERVICES
7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY
7.1 OVERVIEW
7.2 ONCOLOGY AND RADIATION
7.2.1 BY TYPE
7.2.1.1 ONCOLOGY CAD
7.2.1.2 RADIATION THERAPY PLANNING
7.2.2 BY TUMOR TYPE
7.2.2.1 MALIGNANT
7.2.2.2 BENIGN
7.2.3 BY PRODUCT TYPE
7.2.3.1 SOFTWARE
7.2.3.2 SERVICES
7.3 BREAST IMAGING
7.3.1 BY TYPE
7.3.1.1 MAMMOGRAPHY CAD
7.3.1.2 BREAST ULTRASOUND CAD
7.3.2 BY PRODUCT TYPE
7.3.2.1 SOFTWARE
7.3.2.2 SERVICES
7.4 LUNG IMAGING
7.4.1 BY TYPE
7.4.1.1 CHEST X-RAY CAD
7.4.1.2 CHEST CT CAD ON PULMONARY NODULES
7.4.2 BY NODULE SIZE
7.4.2.1 >4MM AND <5MM
7.4.2.2 >5MM
7.4.2.3 3 MM AND < 4MM
7.4.3 BY NODULE
7.4.3.1 PART SOLID NODULES
7.4.3.2 NON- SOLID NODULES
7.4.4 BY NODULE TYPE
7.4.4.1 JUXTAPLEURAL NODULES
7.4.4.2 ISOLATED NODULES
7.4.4.3 GROUND-GLASS NODULES
7.4.5 BY PRODUCT TYPE
7.4.5.1 SOFTWARE
7.4.5.2 SERVICES
7.5 CARDIOVASCULAR IMAGING
7.5.1 BY TYPE
7.5.1.1 CARDIAC CT CAD
7.5.1.2 CARDIAC MRI CAD
7.5.2 BY PRODUCT TYPE
7.5.2.1 SOFTWARE
7.5.2.2 SERVICES
7.6 ABDOMINAL AND PELVIC IMAGING
7.6.1 BY TYPE
7.6.1.1 GASTROINTESTINAL CAD
7.6.1.2 ABDOMINAL CT CAD
7.6.1.3 KIDNEY CAD
7.6.2 BY PRODUCT TYPE
7.6.2.1 SOFTWARE
7.6.2.2 SERVICES
7.6.2.3 DENTAL IMAGING
7.6.3 BY PRODUCT TYPE
7.6.3.1 SOFTWARE
7.6.3.2 SERVICES
7.7 OTHERS
8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 CANCER
8.2.1 BREAST CANCER
8.2.2 COLORECTAL CANCER
8.2.3 LUNG CANCER
8.2.4 PROSTATE CANCER
8.2.5 LIVER CANCER
8.2.6 BONE CANCER
8.2.7 OTHERS
8.2.7.1 SOFTWARE
8.2.7.2 SERVICES
8.3 NEUROLOGICAL DISORDERS
8.3.1 MULTIPLE SCLEROSIS
8.3.2 STROKE
8.3.3 OTHERS
8.3.3.1 SOFTWARE
8.3.3.2 SERVICES
8.4 CARDIOVASCULAR DISEASES
8.4.1 CORONARY ARTERY DISEASE
8.4.2 CONGENITAL HEART DEFECTS
8.4.3 VALVULAR HEART DISEASE
8.4.4 OTHERS
8.4.4.1 SOFTWARE
8.4.4.2 SERVICES
8.5 MUSCULOSKELETAL DISEASES
8.5.1 OSTEOARTHRITIS
8.5.2 RHEUMATOID ARTHRITIS
8.5.3 JOINT DISORDERS
8.5.4 OTHERS
8.5.4.1 SOFTWARE
8.5.4.2 SERVICES
8.6 OTHERS
9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE
9.1 OVERVIEW
9.2 GROUP PURCHASE ORGANIZATIONS
9.3 INDIVIDUAL
10 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 PRIVATE
10.2.2 PUBLIC
10.3 DIAGNOSTIC CENTERS
10.4 RESEARCH CENTERS & ACADEMIC INSTITUTES
10.5 OTHERS
11 COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: U.S.
12 SWOT ANALYSIS
13 COMPANY PROFILES
13.1 FUJIFILM HOLDINGS CORPORATION
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENT
13.2 KONINKLIJKE PHILIPS N.V.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENT
13.3 CANON MEDICAL SYSTEMS CORPORATION
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENT
13.4 SIEMENS HEALTHINEERS AG
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT DEVELOPMENT
13.5 MEDIAN TECHNOLOGIES.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENT
13.6 GENERAL ELECTRIC
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENT
13.7 HOLOGIC INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENT
13.8 ICAD, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENT
13.9 EDDA TECHNOLOGY, INC.
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENT
13.1 RIVERAIN TECHNOLOGIES
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 RELATED REPORTS
List of Table
TABLE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 2 U.S. SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 3 U.S. INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 4 U.S. STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 5 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 6 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 7 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 8 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 9 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 10 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 11 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 12 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 13 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 14 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 15 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 16 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 17 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 18 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 19 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 20 U.S. DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 22 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 24 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 25 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 26 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 27 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 28 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 29 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 31 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 32 U.S. HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
List of Figure
FIGURE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION
FIGURE 2 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DATA TRIANGULATION
FIGURE 3 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DROC ANALYSIS
FIGURE 4 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COUNTRYWISE MARKET ANALYSIS
FIGURE 5 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION
FIGURE 10 INCREASING TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE GROWTH OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 11 SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 AND 2031
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET
FIGURE 13 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023
FIGURE 14 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)
FIGURE 15 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 16 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 17 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023
FIGURE 18 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)
FIGURE 19 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031)
FIGURE 20 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE
FIGURE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023
FIGURE 22 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 23 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 24 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 25 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023
FIGURE 26 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
FIGURE 27 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)
FIGURE 28 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 29 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023
FIGURE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 31 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)
FIGURE 32 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2023 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.